Singulair (Montelukast) Interactions: What to Avoid While Taking It

Alan Lucks | MD

Medically reviewed by Alan Lucks | MD, Alan Lucks MDPC Private Practice - New York on July 27th, 2026.

Published on July 24th, 2026. Updated on July 27th, 2026.

General 5 min

Key takeaways

  • Montelukast is metabolized by specific liver enzymes (CYP3A4 and CYP2C8), making it vulnerable to interactions that can raise or lower its effectiveness.

  • CYP3A4 inducers like rifampin and St. John's Wort are among the most clinically significant interactions, yet patients often overlook them.

  • Alcohol and CNS-active medications can amplify the FDA-warned neuropsychiatric risks associated with montelukast, including mood changes and sleep disturbances.

  • OTC antihistamines like loratadine or cetirizine are generally considered safe alongside montelukast, but confirming with a provider based on your full health picture is still wise.

  • Proactively disclosing all supplements and OTC products to your provider is essential because many high-risk interactions involve substances not commonly perceived as medications.

How Montelukast Works and Why Interactions Matter

Montelukast, sold under the brand name Singulair, belongs to a class of medications called leukotriene receptor antagonists. It works by blocking inflammatory chemicals in the body that trigger asthma attacks and allergy symptoms such as nasal congestion, wheezing, and shortness of breath. For many patients, it is a convenient once-daily option that fits easily into a routine.

What makes montelukast particularly vulnerable to interactions is how the liver processes it. The drug is metabolized primarily through two liver enzyme pathways: CYP3A4 and CYP2C8. When another substance speeds up or slows down these enzymes, the amount of active montelukast circulating in your body changes. Too little means the drug may not adequately control your symptoms. Too much raises the risk of side effects, including the serious neuropsychiatric events flagged by the FDA in a 2020 boxed warning.

Understanding these pathways helps explain why even common supplements or over-the-counter products can matter more than patients might expect.

Drug Interactions That Can Reduce Effectiveness or Raise Risk

Some of the most clinically significant interactions involve prescription medications that strongly influence CYP3A4. Rifampin, an antibiotic used to treat tuberculosis, is a potent CYP3A4 inducer that can dramatically lower montelukast blood levels, potentially allowing asthma symptoms to return or worsen. Anticonvulsants such as phenobarbital, phenytoin, and carbamazepine carry a similar risk because they also induce this enzyme pathway. Patients on these medications may find that montelukast provides less relief than expected, and a provider may need to reassess the treatment plan.

On the other side of the equation, gemfibrozil, a cholesterol-lowering medication, inhibits CYP2C8 and can increase montelukast exposure. Higher drug levels mean a greater chance of experiencing the neuropsychiatric side effects the FDA has warned about, including anxiety, aggression, depression, and sleep disturbances.

Other medications deserve extra attention even without a direct pharmacokinetic interaction. Warfarin and other anticoagulants do not interact with montelukast in a straightforward enzyme-based way, but asthma flares involving inflammation can complicate INR management. Theophylline, sometimes co-prescribed for asthma, has a narrow therapeutic window and warrants closer monitoring when montelukast is added. Aspirin and NSAIDs are also worth discussing: montelukast is sometimes prescribed for aspirin-exacerbated respiratory disease, but it does not fully neutralize NSAID sensitivity, and continued use can still trigger attacks.

Common Interacting Substances at a Glance

Substance or Drug

Type of Interaction

Clinical Concern Level

Rifampin

CYP3A4 inducer, lowers montelukast levels

High

Gemfibrozil

CYP2C8 inhibitor, raises montelukast levels

High

St. John's Wort

CYP3A4 inducer, lowers montelukast levels

High

Phenobarbital / Phenytoin

CYP3A4 inducers, reduce effectiveness

Moderate to High

Alcohol (heavy use)

Liver enzyme stress, neuropsychiatric risk amplification

Moderate to High

Theophylline

Narrow therapeutic window, requires monitoring

Moderate

Warfarin

Indirect clotting dynamic changes during flares

Moderate

OTC antihistamines (newer)

Generally safe, minor sedation overlap with older formulas

Low

Grapefruit juice

Minor CYP3A4 effect, less established clinically

Low

Supplements and OTC Products Often Overlooked

Many patients assume that herbal supplements and over-the-counter products are safe to combine with any prescription medication because they are available without a prescription. With montelukast, this assumption can be problematic.

St. John's Wort is one of the most important examples. It is a potent CYP3A4 inducer, and its effect on lowering montelukast blood levels is comparable to that of rifampin. Because patients often do not think of it as a "real" medication, it frequently goes undisclosed during provider appointments. If you take St. John's Wort for mood support, inform your prescriber so they can evaluate whether your montelukast dose is achieving the intended effect.

Ginkgo biloba and other herbal products with anticoagulant properties add a theoretical bleeding concern when combined with medications affecting inflammatory pathways. High-dose vitamin D and fish oil supplements marketed for allergy or immune support have limited evidence for these indications and should be reviewed with a provider.

On the more reassuring side, newer OTC antihistamines such as loratadine (Claritin) and cetirizine (Zyrtec) are commonly combined with montelukast and are generally considered safe. Older first-generation antihistamines like diphenhydramine (Benadryl) may add sedation effects, which matters for driving, operating machinery, or managing children's daytime activity levels.

Alcohol, Lifestyle, and the Neuropsychiatric Warning

The FDA added a boxed warning to montelukast in 2020 after accumulating reports of serious neuropsychiatric events, including suicidal ideation, hallucinations, anxiety, aggression, and abnormal dreams. This warning applies across all ages and is one of the most important safety considerations for anyone taking this medication.

Alcohol is relevant here for two reasons. First, it can increase the neuropsychiatric side effect burden on its own, particularly in adolescents and adults who already have risk factors for mood disorders. Second, heavy alcohol use stresses the same liver enzyme pathways that metabolize montelukast, leading to unpredictable changes in drug levels. Even moderate alcohol use is worth discussing with a provider if you are taking montelukast long-term.

Smoking is another lifestyle factor that influences liver enzyme activity. Smoking induces CYP1A2 and has some overlap with pathways relevant to montelukast metabolism. For patients who quit smoking while on montelukast therapy, metabolic patterns can shift in ways that may be worth monitoring.

CNS-active medications including antidepressants, benzodiazepines, and sleep aids also deserve extra attention when combined with montelukast. Any substance that raises montelukast blood levels, or that independently affects mood and cognition, can amplify the neuropsychiatric risks the FDA has highlighted. Patients and caregivers should know the warning signs and have a clear plan for contacting a provider promptly if behavioral or mood changes emerge.

Building a Safer Medication Routine

The most practical step any patient can take is to bring a complete and honest medication list to every provider appointment, including prescription drugs, OTC products, vitamins, and herbal supplements. Many high-risk interactions involve substances that patients do not perceive as medications at all.

Doctronic, the first AI legally authorized to practice medicine in the United States, offers a fast and accessible way to review your full medication profile. With free AI consultations and $39 video visits available 24/7, patients can get personalized guidance on possible montelukast interactions without waiting for a scheduled appointment. Whether you are newly starting Singulair, managing a complex medication list, or unsure about a specific supplement, timely review can help you stay both safe and effectively treated.

Frequently Asked Questions

Benadryl (diphenhydramine) is an older antihistamine that may add to drowsiness or sedation when combined with montelukast, particularly in children and older adults. Newer antihistamines like loratadine or cetirizine are generally considered lower risk for this effect. Always confirm with a provider based on your age, dose, and other medications.

Alcohol is best avoided or kept minimal while taking Singulair. It can worsen montelukast's neuropsychiatric side effects, including agitation, depression, and disrupted sleep. Heavy alcohol use also stresses the same liver enzymes that break down montelukast, which may lead to unpredictable changes in how much of the drug remains active in your body.

Some hormonal contraceptives influence CYP liver enzymes, and there is a theoretical possibility of minor interactions with montelukast. Clinical evidence suggesting a meaningful effect is limited, but it is worth mentioning your contraceptive to your provider when reviewing your full medication list so they can assess any individual risk factors.

Yes, it is possible. St. John's Wort is a potent inducer of the CYP3A4 enzyme, which is one of the main pathways the liver uses to break down montelukast. Taking both together may lower montelukast blood levels significantly, potentially reducing its ability to control asthma or allergy symptoms. Stopping St. John's Wort without guidance can also cause rebound changes.

Rifampin is a strong CYP3A4 inducer and can dramatically lower montelukast blood levels, which may make asthma control worse. If rifampin is necessary for your treatment, your provider may need to reassess your asthma or allergy management plan during and after the course of rifampin therapy to ensure your symptoms remain controlled.

The Bottom Line

Montelukast is widely considered well-tolerated, but its reliance on CYP3A4 and CYP2C8 liver enzymes creates real interaction risks that are easy to miss, especially with herbal supplements, enzyme-inducing medications, and everyday habits like drinking alcohol. Substances that raise montelukast levels may amplify the FDA's boxed warning about serious neuropsychiatric events, while those that lower levels can quietly reduce asthma and allergy control. Reviewing your full medication list, including supplements and OTC products, with a clinician is one of the most important steps you can take. Doctronic has completed over 22 million AI consultations, with 99.2% treatment plan alignment with board-certified physicians, and offers free AI consultations or $39 video visits available 24/7 so you can get personalized medication guidance quickly and affordably. This article is informational and is not a medical diagnosis. Confirm with a licensed clinician, especially for new, worsening, or high-risk symptoms.

Get personalized health advice

Chat Now